Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
Clinical trial NCT05305651 · COMPLETED
Trial details
- NCT number
- NCT05305651
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-07-17
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.